Ember LifeSciences: Funding, Investors & Team (Sep 2026)
Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container provides continuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases.
Ember LifeSciences has raised $16.5M across 2 funding rounds on record, the most recent a Series A announced in May 2026.
Ember LifeSciences Company Profile and Key Stats
Latest funding round on record: May 2026.
Ember LifeSciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Ember LifeSciences raised $16.5M in a Series A announced in Dec 2025.
5 months later, a Series A was announced in May 2026 with no disclosed amount.
Ember LifeSciences Founders and Leadership Team
No contact details are on record for this team yet.
Ember LifeSciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Ember LifeSciences in Biotechnology and Los Angeles
Companies Similar to Ember LifeSciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Ember LifeSciences Funding FAQs
What does Ember LifeSciences do?
Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container provides continuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases.
How much funding has Ember LifeSciences raised?
Ember LifeSciences has raised $16.5M across 2 rounds on record.
When did Ember LifeSciences last raise funding?
Ember LifeSciences' most recent funding round on record was announced in May 2026. The amount was not disclosed.
Who founded Ember LifeSciences?
FundedIQ lists Clay Alexander (Founder) at Ember LifeSciences.
Where is Ember LifeSciences headquartered?
Ember LifeSciences is based in Los Angeles, California, United States.
How many employees does Ember LifeSciences have?
Ember LifeSciences is in the 11-50 employee band.
About FundedIQ's Ember LifeSciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ember LifeSciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.